Thalys Medical Technology Group Corporation (SHA:603716)
17.74
-0.93 (-4.98%)
Aug 11, 2026, 3:00 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 3.8 billion as of August 11, 2026. Its market cap has decreased by -26.42% in one year.
Market Cap
3.80B
Enterprise Value
4.08B
Revenue
971.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.74
ChartMarket Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 3.80B, an increase of 92.42%. That is a compound annual growth rate of 6.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 3.80B | -10.37% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.87B |
| Shanghai Runda Medical Technology | 6.36B |
| Maccura Biotechnology Co.Ltd | 5.65B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 3.77B |
| SMO ClinPlus CO.,LTD. | 3.73B |
| Guangdong Hybribio Biotech | 3.67B |